Activity
-
🎉 I want to take a moment to express my heartfelt gratitude to everyone who attended the Johnson & Johnson event at JLABS @ NYC last Thursday, "How…
🎉 I want to take a moment to express my heartfelt gratitude to everyone who attended the Johnson & Johnson event at JLABS @ NYC last Thursday, "How…
Liked by Ginger Liau
-
Jovial JLABS NYC AI in Life Sciences panel! ��� My main takeaway: Life sciences and its enablers are judiciously adopting AI in all stages of drug…
Jovial JLABS NYC AI in Life Sciences panel! 🔬 My main takeaway: Life sciences and its enablers are judiciously adopting AI in all stages of drug…
Liked by Ginger Liau
-
Exited to announce this partnership between Cartography Biosciences and Gilead Sciences! I'm looking forward to working with them as we discover and…
Exited to announce this partnership between Cartography Biosciences and Gilead Sciences! I'm looking forward to working with them as we discover and…
Liked by Ginger Liau
Experience & Education
-
Andreessen Horowitz
View Ginger’s full experience
See their title, tenure and more.
or
Licenses & Certifications
More activity by Ginger
-
New, exciting data from Scribe Therapeutics on our #CRISPR genome and epigenome editing platforms. We continue to share developments in the potency…
New, exciting data from Scribe Therapeutics on our #CRISPR genome and epigenome editing platforms. We continue to share developments in the potency…
Liked by Ginger Liau
-
Congratulations to Matthew Hill and the ELEGEN team on securing $35M in Series B funding! This raise will accelerate Elegen's efforts to remove…
Congratulations to Matthew Hill and the ELEGEN team on securing $35M in Series B funding! This raise will accelerate Elegen's efforts to remove…
Liked by Ginger Liau
-
We're excited to announce Chapter’s Series C financing. Five years ago, there wasn't a Medicare navigator that I would have felt comfortable…
We're excited to announce Chapter’s Series C financing. Five years ago, there wasn't a Medicare navigator that I would have felt comfortable…
Liked by Ginger Liau
-
🚀 Big news! 🚀 After a tremendous ride for the past four years on the venture side at Andreessen Horowitz, it’s time for me to get back to…
🚀 Big news! 🚀 After a tremendous ride for the past four years on the venture side at Andreessen Horowitz, it’s time for me to get back to…
Liked by Ginger Liau
-
Excited for this R&D collaboration between the Johnson & Johnson Innovative Medicine and BigHat Biosciences teams to advance the discovery and design…
Excited for this R&D collaboration between the Johnson & Johnson Innovative Medicine and BigHat Biosciences teams to advance the discovery and design…
Liked by Ginger Liau
-
It was great to sit down with Peter Neumann today at the Center for the Evaluation of Value and Risk in Health (CEVR) annual meeting. We discussed a…
It was great to sit down with Peter Neumann today at the Center for the Evaluation of Value and Risk in Health (CEVR) annual meeting. We discussed a…
Liked by Ginger Liau
-
As a follow up to my last post, here's a list of some of the best executive/startup coaches that folks mentioned. Incredible group here. Lenn Pryor…
As a follow up to my last post, here's a list of some of the best executive/startup coaches that folks mentioned. Incredible group here. Lenn Pryor…
Liked by Ginger Liau
-
I am happy to share that I started a new position as Chief CMC Officer at Alnylam Pharmaceuticals.
I am happy to share that I started a new position as Chief CMC Officer at Alnylam Pharmaceuticals.
Liked by Ginger Liau
-
This week, I represented the GSK BD team at the Biopharma M&A Panel during the Leerink Partners Global Biopharma Conference. It was a deep dive into…
This week, I represented the GSK BD team at the Biopharma M&A Panel during the Leerink Partners Global Biopharma Conference. It was a deep dive into…
Liked by Ginger Liau
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More